Tue, Jul 7, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Saemor Capital fund returns 9.3% in H1, complies with AIFMD

Friday, July 25, 2014

Komfie Manalo, Opalesque Asia:

Quantitative investment management specialist Saemor Capital B.V., reported that its Saemor Capital Europe Alpha Fund returned 9.3% in the first half of 2014 (+6.5% in June), the highest in the equity market neutral and quantitative group categories.

Saemor Capital’s Founder and CEO Sven Bouman said a pro-risk approach at the start of the year and subsequently a more cautious portfolio stance have worked out well.

"The long as well as the short book of the fund performed well. Almost every sector made a positive contribution. On a stock level, long positions Actelion, Pandora, Enel, Statoil and Yara were instrumental. Several short positions also added to the performance as their share prices came under pressure after issuing a profit warning," he said.

Bouman continued, "Our quantitative stock selection model posted very solid returns. We look at roughly 50 factors in four quadrants: valuation, momentum, profitability & growth and quality. For the year almost all the factors we look at are in black with earnings revisions being the standout performer. Value factors are second-to-best. Early in the year investors were buying stocks with low cyclical valuation like price-to-book. Subsequently the more defensive value factors started to do well as economic data started to come in below expectations. As a result high dividend stocks came back in favor, helped by the low interest rate ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner